Medicamen Biotech P/E Ratio

Current P/E Ratio
42.61
High Valuation
Very High - High growth expectations or significantly overvalued

Medicamen Biotech P/E ratio. Medicamen Biotech (MEDICAMEQ) P/E ratio is 42.61 (High), EPS (TTM) ₹7.22, current price ₹345.50 on NSE vs historical average P/E of 74.05 (14.3th percentile) — Very High - High growth expectations or significantly overvalued. For live price, revenue and the complete fundamental profile, see Medicamen Biotech share price today.

Current Valuation Metrics

P/E Ratio 42.61
Current Price ₹345.50
EPS (TTM) ₹7.22
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 74.05
Historical Range 30.93 - 112.62
Percentile 14.3%

Sector Context

Sector Average 56.26
Sector Median 32.41
Sector Rank #11 of 199
Sector Percentile 5.5%

Earnings Breakdown (TTM)

TTM EPS ₹7.67
Mar 2026 ₹3.28
Jun 2026 ₹1.36

MEDICAMEQ P/E Ratio — Valuation Signal & Historical Context

Medicamen Biotech P/E 42.61 vs historical average 74.05, range 30.93–112.62 — signal: Overvalued. Also explore MEDICAMEQ price movement history to track price trends across different timeframes.

  • Stock appears overvalued with PE of 42.61, suggesting caution for new investments
  • Current PE is 42.5% below historical average
  • Trading at discount to sector average PE of 56.26

Medicamen Biotech P/E Ratio Historical Trend

MEDICAMEQ annual price-to-earnings ratio — 7 years, EPS and year-end price. Current P/E 42.61 vs historical average 74.05. Examine MEDICAMEQ quarterly trends for recent quarterly revenue, profit and EPS trends.

MEDICAMEQ Historical P/E Ratio — EPS, Year-End Price & Valuation

Medicamen Biotech annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 93.21 5.42 ₹505.20 NSE High
2024 112.62 5.25 ₹591.25 NSE High
2023 97.16 8.92 ₹866.70 NSE High
2022 88.94 11.02 ₹980.10 NSE High
2021 42.66 12.94 ₹552.00 NSE High
2020 52.86 9.0 ₹475.75 BSE High
2019 30.93 11.04 ₹341.50 BSE High

MEDICAMEQ vs Healthcare Peers — P/E Ratio Comparison

Medicamen Biotech P/E 42.61 vs Healthcare average 56.26, median 32.41 — range 2.04–740.29.

Sector Average
56.26
Sector Median
32.41
Lowest P/E
2.04
Highest P/E
740.29
Companies
199
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Sunrest Lifescience SUNREST 2.04 ₹65 Low
Murae Organisor MURAE 2.86 ₹41 Low
Phaarmasia PHRMASI 3.41 ₹63 Low
Sun Pharma Advanced Rese… SPARC 3.98 ₹6,206 Low
Dipna Pharmachem DPL 4.57 ₹12 Low
JFL Life Sciences JFLLIFE 4.88 ₹66 Low
GKB Ophthalmics GKB 5.88 ₹32 Low
Kabra Drugs KABRADG 6.09 ₹44 Low
Royal Sense ROYAL 6.58 ₹47 Low
Colinz Laboratories COLINZ 6.62 ₹18 Low